Skip to main content
Figure 1 | Genetic Vaccines and Therapy

Figure 1

From: Application of a haematopoetic progenitor cell-targeted adeno-associated viral (AAV) vector established by selection of an AAV random peptide library on a leukaemia cell line

Figure 1

Gene transfer efficiency of the rAAV capsid mutants and control vectors on a panel of leukaemia cell lines (in % GFP+ cells) using an MOI of 100. Cell lines: BV173: CML blast crisis (lymphoid); EM3: CML blast crisis relapse; HL60: AML (M2); K562: CML blast crisis (erythroid); KG1a: AML (erythro-leukaemia); Lama84: CML blast crisis. Random = randomly generated capsid mutant rAAV vector. Data are given as mean ± SD (n ≥ 3). * = rAAV capsid mutants significantly (p < 0.001) more efficient than standard rAAV2. + = as *, but with p < 0.01.

Back to article page

Genetic Vaccines and Therapy

ISSN: 1479-0556